adenosine 3'-phosphate-5'-phosphate has been researched along with aspartic acid in 3 studies
| Studies (adenosine 3'-phosphate-5'-phosphate) | Trials (adenosine 3'-phosphate-5'-phosphate) | Recent Studies (post-2010) (adenosine 3'-phosphate-5'-phosphate) | Studies (aspartic acid) | Trials (aspartic acid) | Recent Studies (post-2010) (aspartic acid) |
|---|---|---|---|---|---|
| 102 | 0 | 34 | 23,005 | 417 | 4,018 |
| Protein | Taxonomy | adenosine 3'-phosphate-5'-phosphate (IC50) | aspartic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.638 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 90.1265 | |
| Excitatory amino acid transporter 2 | Homo sapiens (human) | 11 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 1.638 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 1.638 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enkvist, E; Järv, J; Kelve, M; Raidaru, G; Sak, K; Subbi, J; Uri, A | 1 |
| Fuda, H; Lee, KA; Lee, YC; Negishi, M; Pedersen, LC; Strott, CA | 1 |
| An, XM; Chang, WR; Li, HT; Li, M; Liu, MC; Lu, JH; Zhang, JP | 1 |
3 other study(ies) available for adenosine 3'-phosphate-5'-phosphate and aspartic acid
| Article | Year |
|---|---|
Adenosine-derived non-phosphate antagonists for P2Y(1) purinoceptors.
Topics: Adenosine; Adenosine Diphosphate; Aspartic Acid; Astrocytoma; Dose-Response Relationship, Drug; Humans; Phosphates; Phosphatidylinositols; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Thionucleotides; Tumor Cells, Cultured | 2000 |
Crystal structure of human cholesterol sulfotransferase (SULT2B1b) in the presence of pregnenolone and 3'-phosphoadenosine 5'-phosphate. Rationale for specificity differences between prototypical SULT2A1 and the SULT2BG1 isoforms.
Topics: Adenosine Diphosphate; Aspartic Acid; Binding Sites; Cholesterol; Crystallization; Crystallography, X-Ray; Dehydroepiandrosterone; Escherichia coli; Gene Expression; Humans; Hydrogen Bonding; Isoenzymes; Lysine; Models, Molecular; Molecular Structure; Pregnenolone; Protein Structure, Secondary; Recombinant Fusion Proteins; Substrate Specificity; Sulfotransferases; Transfection | 2003 |
Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate.
Topics: Adenosine Diphosphate; Amino Acid Motifs; Arylsulfotransferase; Aspartic Acid; Crystallography, X-Ray; Dopamine; Glutamine; Humans; Ligands; Manganese; Models, Molecular; Protein Binding; Protein Conformation; Static Electricity; Stereoisomerism; Sulfotransferases | 2005 |